Lyndsey Elizabeth Crennen Sells 118 Shares of Mesa Laboratories (NASDAQ:MLAB) Stock

Mesa Laboratories, Inc. (NASDAQ:MLAB) CAO Lyndsey Elizabeth Crennen sold 118 shares of the stock in a transaction on Tuesday, June 16th. The shares were sold at an average price of $101.27, for a total transaction of $11,949.86. Following the transaction, the chief accounting officer directly owned 1,473 shares in the company, valued at approximately $149,170.71. The trade was a 7.42% decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. The sale was made to cover tax withholding obligations related to the vesting of equity awards.

Mesa Laboratories Stock Up 0.2%

MLAB stock opened at $95.10 on Friday. The stock has a market capitalization of $524.95 million, a P/E ratio of 79.25 and a beta of 0.94. The firm has a 50-day simple moving average of $101.92 and a 200-day simple moving average of $90.74. The company has a quick ratio of 1.29, a current ratio of 1.72 and a debt-to-equity ratio of 0.78. Mesa Laboratories, Inc. has a 52 week low of $55.45 and a 52 week high of $113.99.

Mesa Laboratories (NASDAQ:MLAB) last released its quarterly earnings results on Wednesday, May 27th. The medical instruments supplier reported $1.53 earnings per share for the quarter, missing the consensus estimate of $1.78 by ($0.25). The company had revenue of $63.72 million for the quarter, compared to analyst estimates of $65.21 million. Mesa Laboratories had a return on equity of 20.96% and a net margin of 2.69%.During the same quarter last year, the company earned ($1.31) EPS.

Mesa Laboratories Dividend Announcement

The company also recently announced a quarterly dividend, which was paid on Monday, June 15th. Shareholders of record on Friday, May 29th were issued a dividend of $0.16 per share. The ex-dividend date of this dividend was Friday, May 29th. This represents a $0.64 dividend on an annualized basis and a dividend yield of 0.7%. Mesa Laboratories’s dividend payout ratio is presently 53.33%.

Wall Street Analyst Weigh In

Separately, Weiss Ratings downgraded Mesa Laboratories from a “sell (d+)” rating to a “sell (d)” rating in a research report on Wednesday, June 3rd. Two analysts have rated the stock with a Hold rating and one has given a Sell rating to the stock. Based on data from MarketBeat.com, the company has an average rating of “Reduce” and an average target price of $94.00.

Hedge Funds Weigh In On Mesa Laboratories

Several hedge funds and other institutional investors have recently modified their holdings of the business. Simcoe Capital Management LLC acquired a new position in Mesa Laboratories during the third quarter worth about $12,794,000. Boston Partners raised its holdings in Mesa Laboratories by 2,009.5% in the 3rd quarter. Boston Partners now owns 114,357 shares of the medical instruments supplier’s stock valued at $7,664,000 after acquiring an additional 108,936 shares during the last quarter. Roubaix Capital LLC purchased a new position in Mesa Laboratories in the 3rd quarter worth approximately $5,137,000. Millennium Management LLC lifted its stake in Mesa Laboratories by 131.9% in the 3rd quarter. Millennium Management LLC now owns 133,817 shares of the medical instruments supplier’s stock worth $8,967,000 after purchasing an additional 76,107 shares in the last quarter. Finally, Mason Capital Management LLC purchased a new position in Mesa Laboratories in the 3rd quarter worth approximately $4,711,000. 90.60% of the stock is owned by hedge funds and other institutional investors.

About Mesa Laboratories

Mesa Laboratories, Inc (NASDAQ: MLAB) is a global provider of instrumentation products designed for critical process monitoring, testing and calibration. Headquartered in Lakewood, Colorado, the company serves a diverse set of end markets including healthcare, pharmaceutical, food and beverage, energy and industrial sectors. With a focus on precision measurement and validation, Mesa Laboratories helps customers ensure regulatory compliance, product safety and operational efficiency across complex manufacturing and sterilization processes.

The company’s product portfolio encompasses biological and chemical indicators for sterilization process validation, digital data loggers and sensors for environmental monitoring, and optical gas analyzers with sample-conditioning solutions for oil, gas and petrochemical applications.